About GI Dynamics (ASX:GID)
GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.
Industry, Sector and Symbol
Industry Medical Appliances & Equipment
Trailing P/E Ratio-0.733333333333333
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-6,708.12%
Return on Assets-142.93%
GI Dynamics (ASX:GID) Frequently Asked Questions
What is GI Dynamics' stock symbol?
GI Dynamics trades on the ASX under the ticker symbol "GID."
Who are some of GI Dynamics' key competitors?
Some companies that are related to GI Dynamics include Sonoma Pharmaceuticals (SNOA), Auris Medical (EARS), Biocept (BIOC), Zosano Pharma (ZSAN), Soleno Therapeutics (SLNO), Onconova Therapeutics (ONTX), Orexigen Therapeutics (OREX), Cellectar Biosciences (CLRB), Ritter Pharmaceuticals (RTTR), Anthera Pharmaceuticals (ANTH), OHR Pharmaceutical (OHRP), OncoGenex Pharmaceuticals (ACHV), Fibrocell Science (FCSC), TrovaGene (TROV), Xenetic Biosciences (XBIO), LiDCO Group (LID), Dynatronics (DYNT) and Check Cap (CHEK).
Who are GI Dynamics' key executives?
GI Dynamics' management team includes the folowing people:
- Scott Schorer, President, Chief Executive Officer (Age 47)
- Brian Callahan, Executive Vice President - Clinical, Regulatory and Quality, Chief Compliance Officer (Age 49)
- Daniel Jeffrey Moore, Non-Executive Chairman of the Board (Age 56)
- Juliet Thompson, Director
- Timothy Joseph Barberich, Independent Non-Executive Director (Age 69)
- Oern R. Stuge M.D., Independent Non-Executive Director (Age 62)
What is GI Dynamics' stock price today?
One share of GI Dynamics stock can currently be purchased for approximately A$0.02.
How big of a company is GI Dynamics?
GI Dynamics has a market capitalization of $12.17 million.
How can I contact GI Dynamics?
GI Dynamics' mailing address is 1 Maguire Rd, LEXINGTON, MA 02421-3114, United States. The company can be reached via phone at +1-781-3573310.
MarketBeat Community Rating for GI Dynamics (GID)MarketBeat's community ratings are surveys of what our community members think about GI Dynamics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
GI Dynamics (ASX:GID) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for GI Dynamics (ASX:GID)
No earnings announcements for this company have been tracked by MarketBeat.com
GI Dynamics (ASX:GID) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for GI Dynamics (ASX:GID)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for GI Dynamics (ASX GID)
No insider trades for this company have been tracked by MarketBeat.com
GI Dynamics (ASX GID) News Headlines
GI Dynamics (ASX:GID) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
GI Dynamics (ASX GID) Stock Chart for Wednesday, January, 17, 2018